Published 2012
Table of Contents:
“…Contents:
Epigenetics -- levels of control -- The patient cancer journey-multiple impact points -- Key translational areas for
epigenetics -- DNA methylation as cancer biomarker -- DNA methylation analysis methods --
Epigenetic gene silencing in malignant cells -- CpG methylation and clinical outcome -- Causes of aberrant DNA methylation in cancer -- Stem cell targets -- EZH2 as a potential anti-cancer target --
Epigenetic modification as drug targets --
Epigenetic therapies -- DNA methylation versus platinum resistance -- Phase II trial of Decitabine & Carboplatin -- Effects of low doses of DNA-demethylation agents --
Epigenetic therapies challenges.…”
Call Number:
Loading…
Located:
Loading…
Get full text
Series
Electronic
Video